FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon, the global leader in eye care dedicated to helping people see brilliantly, will present key data highlighting advancements in vitreoretinal surgery during ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced results from time and motion studies demonstrating superior efficiency* with UNITY® ...

Attendees can experience a first look at Voyager DSLT, Alcon’s new first-line laser therapy for glaucoma patients Alcon (ALC) introduces new handheld gas delivery systems, UNIFEYE and UNIPEXY, ...

GENEVA & DURHAM, N.C.--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”), a ...

“Alcon has a long legacy of advancing phaco and vitreoretinal technology for surgical ophthalmology. With UNITY VCS/CS, we are introducing more than a dozen innovations designed to transform surgical ...

Alcon, the global leader in eye care and a division of Novartis, launches the Ngenuity 3D Visualization System, a platform for Digitally Assisted Vitreoretinal Surgery (DAVS). The system is designed ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Alcon Plc’s (NYSE:ALC) Tryptyr (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for signs and symptoms of Dry Eye ...

CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST.

STAAR Surgical said shareholders rejected its merger with Alcon, ending the $1.6 billion deal. The eye care company will ...